Avidity Biosciences rallies $16 mln Series B
La Jolla, California-based Avidity Biosciences, a biotech company, has raised $16 million in Series B financing. Takeda Pharmaceuticals led the round with participation from other investors that included Alethea Capital, Alexandria Real Estate Equities, Brace Pharma, EcoR1 Capital, F-Prime Capital, Moore Venture Partners and Tavistock Life Sciences.
5 January 2017•1 min read
